- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07930390
Handheld Fan Direction for Breathlessness in Chronic Heart and Lung Disease
Fan-to-Face Versus Fan-to-Leg Versus No Fan on Exertional Breathlessness and Exercise Capacity With Stable Chronic Cardiopulmonary Disease: A Mixed Method Three-Arm Randomized Controlled Trial
People with chronic heart failure or chronic lung disease (such as COPD or interstitial lung disease) often feel short of breath when they exert themselves. A handheld fan blowing air on the face may ease this feeling, but it is not clear whether the benefit lasts with longer home use, whether it depends on the direction of the airflow, or whether it works in patients with heart disease and in hot climates.
This study will compare three conditions in adults with stable chronic heart and/or lung disease who become breathless on exertion: (1) a handheld fan directed at the face, (2) a handheld fan directed at the leg, and (3) no fan (usual care). Participants will be randomly assigned (1:1:1) to one of the three groups. The two fan groups will use the fan at home for 12 weeks. The no-fan group will receive a fan after the final assessment. The person measuring outcomes will not know which group each participant is in.
The main outcome is breathlessness (Borg 0-10 scale) in the 5 minutes after a 6-minute walk test at week 12. Other outcomes include walking distance, recovery time, breathlessness severity and impact (Dyspnoea-12), functional class, global change in breathlessness, fan use and acceptability, and emergency visits or hospital admissions.
The study also includes interviews with about 24 to 30 participants from the three groups after week 12, to understand how the fan was used, how acceptable it was, and how heat and humidity affected it. Trial and interview findings will be analysed separately and then combined.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Mohamed Fakhry Ahmed Salem, PhD
- Telefonnummer: 01286038014
- E-post: Mohamed.Fakhry@alexu.edu.eg
Studiesteder
-
-
-
Alexandria, Egypt, 21511
- Faculty of Nursing, Alexandria University
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Adults with chronic heart failure and/or chronic lung disease (for example chronic obstructive pulmonary disease or interstitial lung disease) confirmed by a cardiologist or chest physician
- Stable condition: heart failure NYHA class II to III, and no exacerbation of lung disease in recent weeks, confirmed with the treating specialist
- Breathlessness on exertion, with an MRC dyspnoea grade and a Borg score after the 6-minute walk test at or above a minimum set in advance [FILL: e.g. Borg >= 3]
- Stable medication, with no marked change in recent weeks [FILL: period set by the treating specialist]
- Able to walk, answer the questionnaires and give written informed consent
Exclusion Criteria:
- Acute heart failure, an acute exacerbation of lung disease, or a recent hospital admission
- Another dominant cause of breathlessness (for example severe anemia, pulmonary embolism or neuromuscular disease)
- Severe lung disease needing oxygen at rest
- Unstable angina, recent myocardial infarction, or any condition that prevents walking or raises risk
- Cognitive impairment that prevents responding, or inability to use the fan
- Participation in another trial
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Fan-to-Face
Handheld battery-operated fan directed at the face whenever the participant feels breathless, for 12 weeks at home. Participants receive training and a teach-back check at week 0 and keep a daily diary. Usual care continues unchanged. |
Battery-operated handheld fan (same model and speed in both fan arms) directed at the face at a distance of about 15 to 30 cm whenever the participant feels breathless, for a set time per use after training. Used at home for 12 weeks. |
|
Eksperimentell: Fan-to-Leg
Same handheld fan (same model and speed) directed at the leg at the same distance and for the same duration whenever the participant feels breathless, for 12 weeks at home. Training, teach-back, diary and usual care are the same as in the fan-to-face arm. |
The same handheld fan directed at the leg at the same distance and for the same duration per use. Used at home for 12 weeks as an active comparator. |
|
Ingen inngripen: No Fan
Usual care for the heart or lung disease for 12 weeks, with a daily diary of breathless episodes and the same visit and phone-call schedule. After the 6-minute walk test, participants rest seated for 5 minutes without a fan. A fan is offered after the week 12 assessment. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Breathlessness intensity (Borg CR10) after the 6-minute walk test
Tidsramme: Week 12
|
Breathlessness rated on the Borg CR10 scale (0 = nothing at all, 10 = maximal; higher is worse) during the 5 minutes of seated recovery after a 6-minute walk test, with a fan (fan-to-face and fan-to-leg arms) or seated rest without a fan (no-fan arm). Rated at minutes 1, 3 and 5; the minute used for the primary analysis is [FIX BEFORE SUBMITTING]. The walk test is done without a fan in all arms. |
Week 12
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
6-minute walk distance
Tidsramme: Week 0 and week 12
|
Distance walked in 6 minutes. |
Week 0 and week 12
|
|
Recovery time after exertion
Tidsramme: Week 0 and week 12
|
Minutes from the end of the walk test until Borg breathlessness first returns to the pre-test value, asked every minute for 5 minutes (censored at 5 minutes). |
Week 0 and week 12
|
|
Borg CR10 breathing discomfort
Tidsramme: Week 0 and week 12
|
Borg CR10 rating of breathing discomfort (0 to 10, higher is worse), assessed before and at the end of the 6-minute walk test. |
Week 0 and week 12
|
|
Dyspnoea-12 total score
Tidsramme: Week 0 and week 12
|
12 breathlessness descriptors, each scored 0 to 3; total 0 to 36 (higher is worse), with physical (0 to 21) and affective (0 to 15) components. |
Week 0 and week 12
|
|
Functional class
Tidsramme: Week 0 and week 12
|
NYHA class (I to IV) in heart failure participants, and MRC dyspnoea grade (1 to 5) in all participants. Higher is worse. |
Week 0 and week 12
|
|
Borg CR10 leg effort
Tidsramme: Time Frame: Week 0 and Week 12
|
Borg CR10 rating of leg effort (0 to 10, higher is worse), assessed before and at the end of the 6-minute walk test. |
Time Frame: Week 0 and Week 12
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Qualitative experience, acceptability and context
Tidsramme: Within 7 days after the week 12 visit
|
Semi-structured interviews (30 to 45 minutes) with about 24 to 30 participants on how the fan was used, perceived mechanism, barriers, and effect of heat and humidity. Reflexive thematic analysis. |
Within 7 days after the week 12 visit
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Mohamed Fakhry Ahmed Salem, PHD, Alexandria University
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- FANCP-2026-01
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .